Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma

Description

To learn about the possible effects of a prebiotic food-enriched diet (PreFED) targeting the gut microbiome in participants with melanoma who are starting immune checkpoint blockade (ICB) therapy.

Conditions

Unresectable Melanoma

Study Overview

Study Details

Study overview

To learn about the possible effects of a prebiotic food-enriched diet (PreFED) targeting the gut microbiome in participants with melanoma who are starting immune checkpoint blockade (ICB) therapy.

Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma

Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma

Condition
Unresectable Melanoma
Intervention / Treatment

-

Contacts and Locations

Houston

MD Anderson Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age ≥18 years old
  • * Able to self-complete study assessments monitoring diet and gastrointestinal symptom burden
  • * Body mass index (BMI) 18.5-45 kg/m2
  • * ECOG performance status of 0 or 1
  • * Histologically confirmed stage III/IV, unresectable cutaneous or mucosal melanoma. Asymptomatic brain metastases are allowed.
  • * Planned initiation of 1st line standard-of-care approved immune checkpoint blockade (anti-PD1 +/- anti-CTLA4 or anti-LAG3 inhibitors) in the metastatic setting (prior ICB in adjuvant setting is allowed if last exposure ≥ 6 months prior). Prior targeted therapy is also allowed.
  • * Returning to MD Anderson for restaging and follow-up (ICB treatment may occur locally)
  • * WOCP must have negative UPT within 1 week of beginning dietary intervention.
  • * Self-reported willingness to eat the provided foods (with some tailoring to their food preferences)
  • * Self-reported willingness to comply with scheduled visits, undergo venipuncture, provide stool samples.
  • * Uveal melanoma previous ICB treatment in the metastatic setting
  • * History of inflammatory bowel disease, total colectomy, or bariatric surgery.
  • * Currently taking steroids \> Prednisone 10 mg/day or equivalent
  • * Medical contraindications to the Intervention Diet as determined by the treating physician.
  • * Self-reported major dietary restrictions, including but not limited to relevant food allergies, celiac disease, or diets such as vegan, ketogenic, extended fasting.
  • * Insulin-dependent diabetes or condition requiring bile acid sequestrants
  • * Unable or unwilling to undergo study procedures.
  • * IV antibiotic use in the past month or oral antibiotic use in past 2 weeks.
  • * Regularly taking supplements containing prebiotics, fiber and/or probiotics, and unable/unwilling to discontinue for the purpose of the study.
  • * Current smoker or heavy drinker (defined as \>14 drinks per week) or current illicit drug use.
  • * Currently pregnant, planning to become pregnant, or lactating.
  • * Concurrent malignancy requiring systemic therapy other than hormonal therapy.
  • * Cognitively impaired adults

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

M.D. Anderson Cancer Center,

Jennifer McQuade, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

2029-06-30